# Fecal Microbiota Transplantation for the Treatment of Severe Acute Gut Graft-Versus-Host Disease

> **NCT04280471** · PHASE1 · WITHDRAWN · sponsor: **Jonsson Comprehensive Cancer Center**

## Conditions studied

- Acute Graft Versus Host Disease
- Gastrointestinal Tract Acute Graft Versus Host Disease
- Severe Gastrointestinal Tract Acute Graft Versus Host Disease
- Steroid Resistant Gastrointestinal Tract Acute Graft Versus Host Disease

## Interventions

- **DRUG:** Fecal Microbiota Transplantation Capsule

## Key facts

- **NCT ID:** NCT04280471
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-09-01
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was not opened
- **Last updated:** 2023-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04280471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04280471, "Fecal Microbiota Transplantation for the Treatment of Severe Acute Gut Graft-Versus-Host Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04280471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*